Rasheed Abiodun Balogun
A N Karopadi
K S Nayak
Emaad Abdel Rahman
Prof. Akihiro C. Yamashita
Professor Akihiro C. Yamashita was born in April 7, 1957 in Ibaraki Prefecture and was grown up in Tokyo, Japan. After graduating from Waseda University in Tokyo with a degree of BS in 1980, he worked for a hospital as a biomedical researcher as well as for Waseda University and Kitasato University as a lecturer. In 1991, he went to the University of Texas at Austin, U.S.A., seeking for an advanced degree. He finished his graduate work related to peritoneal dialysis in 1991 with a degree of Ph.D. under the directions of Drs. Robert P. Popovich and Jack W. Moncrief.
After returning to Japan, Dr. Yamashita served as an assistant professor in Kyushu Institute of Technology from 1991 to 1999. He made an appointment to serve as an associate professor in Shonan Institute of Technology (SIT) in 1999 and became a professor in 2004 at the same university. Dr. Yamashita moved from SIT to Hosei University in 2013 and is currently serving as a professor of the department of Chemical Science and Technology.
Since he is originally a chemical engineer, his research interest is always based on fundamental theories. He is, however, collaborating with many local doctors mostly working in the field of dialysis, he has a wide variety of knowledge related to dialysis from the basic to the clinical problems. He had a chance to serve as a President of the annual conferences of JS-HDF in 2003, JSPD in 2006 and JSAO in 2017.
Strategy and M & A Consulting, Associate Consultant at Alira Health, Munich, Germany. A N Karopadi has Authored 30 scientific publications (13 lead author publications, and ~450 citations) in International Journals and Co-authored Harvard Business Review article with Professor Govindarajan (Tuck School of Business, USA).
He was Invited as a speaker on topic “Global Dialysis Costs” at the 32nd International Congress on Dialysis in Vicenza, Italy (2014). He is also an Editorial board member of two journals and reviewer for 5 journals including Peritoneal Dialysis International Canada.
· 2016: Fellow of Indian College of Critical Care Medicine
· 2015: Diploma in Medical Law and Ethics – NLSIU
· 2013: Diploma in Health Care Quality , Apollo Medvarsity
· 2006: European Diploma in Intensive Care
· 2004: Fellowship of National Board in Critical Care Medicine
· 2002: DNB Internal Medicine
· 2000: MD (Internal Medicine) , NTRUHS
· Advanced diploma in animations and graphics
· Certificate in ICU Sonography, University of Melbourne
May 2015- March 2016
Director Critical Care , Century Superspecialty Hospital, Hyderabad
· The hospital is a 400 bed tertiary care facility with 44 Intensive Care Beds
· Worked as director of critical care for the group of hospitals.
· Responsible for organizing services related to the specialty
· Director of training for ISCCM and NBE courses in Critical Care
· Chairperson of hospital infection control committee from 2009-2014
· Member of Medical Advisory Committee
· Member of clinical pathways committee
January 2005- February 2006 –
Registrar in ICU, Westmead Hospital, NSW, Australia
· Worked as a registrar in a referral ICU with focus on Neuro Intensive Care
August 2002 – June 2004 –
· Fellow in Critical Care, Manipal Hospital, Bangalore
August 2000 – August 2001 –
· Registrar in Internal Medicine, Mediciti Hospital, Hyderabad
Role of urinary NGAL in Critically ill Patients, Blood Purification
Audit of Transport of Critically Ill Patients, IJCCM
Role of Heparin Binding Protein in Septic Shock, IJCCM
Nutritional Assessment of Critically Ill Patients ASPEN
Therapeutic Plasma Exchange in Critical Illness IJCCM
Outcomes of patients with Acute on chronic renal failure in Intensive Care Blood Purif Feb 2007
Outcomes of patients with Leptospirosis needing Intensive Care , Blood Purif Feb 2007
Glycemic control in Intensive Care – Critical Care Update 2004 Ed Nayyar
Does it matter how we treat Phenobarbitone overdose of moderate severity IJCCM Sep 2006
An Audit of Central Venous Cannulations – IJCCM March 2006
Memberships and affiliations
Life member of ISCCM
Life member of API
Life member of ISPEN
Member of European Society of Intensive Care Medicine
Member of Society of Critical Care Medicine, USA
Member of Neuro Critical Care Society
Chairman of Guidelines committee of ISCCM from 2015- 2018
ELECTED AS GENERAL SECRETARY OF ISCCM FOR 2019 -2021
Accredited teacher for critical care courses offered by NBE
Faculty at Criticare since 2007
Faculty at numerous national workshops and conferences
Chairman Scientific Committee for Criticare 2010 Hyderabad
Claudio Ronco graduated in medicine from the University of Padua, Italy in 1976. He specialized in nephrology at the University of Padua in 1979 and in paediatric nephrology at the University of Naples in 1989. From 1977 to 1998 Claudio was the Assistant and Associate professor at the Division of Nephrology in Vicenza. From 1999 to 2001 he was the Director of the Renal Laboratory at the Renal Research Institute and Professor of Medicine at the Albert Einstein College of Medicine and Beth Israel Medical Centre of New York. Since 2002 Claudio is the Director of Department of Nephrology at St. Bortolo Hospital, Vicenza, Italy and presently a full Professor at the University of Padua, Italy. He has co-authored 994 papers, 85 book chapters and 62 books, and has delivered more than 650 lectures at international meetings and universities. He is a council member of several scientific societies and editor emeritus of the International Journal of Artificial Organs. He is also Editor-in-Chief of Blood Purification and Contributions to Nephrology. Professor Ronco has received numerous honours and awards including, in 2004, the lifetime achievement award and honorary membership in the Spanish Society of Nephrology, the National Kidney Foundation International Medal of Excellence and in 2009, the ISN Bywaters Award for Acute Renal Failure
Consultant nephrologist at the Sheffield Teaching Hospital NHS Foundation Trust since August 1995 leading a programme of home haemodialysis and peritoneal dialysis, with a research interest in dialysis outcomes. Editor In Chief Peritoneal Dialysis International and Co-program chair for ISPD/EuroPD Glasgow May 2020. Chief investigator UK Catheter study (NIHR RFPB) and team member PDOPPS. Clinical Lead for Scaling Up Shared Haemodialysis Care programme funded by the Health Foundation. Divisional lead for Yorkshire and Humber Clinical Research Network.
Prof. Goce Spasovski, MD, PhD
Goce Spasovski is from Macedonia, postgraduated in nephrology at the Un. at the University of Antwerp, Katowice and “Laiko” University Hospital in Athens, PhD at the Universities of Skopje and Antwerp. He was PI in 20 clinical trials related to progression of CKD (currently two FP7 projects), anaemia, CKD-MBD and bone biopsy based studies, immunotolerance in kidney transplant recipients etc. He finished his term as an ERA-EDTA Ordinary Council Member in 2009, then he was a Chairman of the Committee for CME activities at ERA-EDTA up to 2013/14, ERBP advisory board member, Co-Chairman of the ERBP hyponatraemia group, member of the ERBP transplant guideline and DESCARTES group, current EDTA Council 2016/19. He is also a President of the Macedonian Society of Nephrology, Dialysis, Transplantation and Artificial Organs, ISBP Board member since 2018, member of the ISN GO Central & East European Committee, EUTox group, the KDIGO Implementation Task Force leader for central and east Europe. His academic opus has more than 459 published articles and book chapters (147 medline cited), 4630 citations and Hirsh index of 33.
Prof. Philip Kam-Tao Li is the Chief of Nephrology & Consultant Physician of the Department of Medicine and Therapeutics at the Prince of Wales Hospital (PWH), Hong Kong. He is also the Honorary Professor of Medicine at the Chinese University of Hong Kong. Prof. Li is the President of Asian Pacific Society of Nephrology and Past President of International Society for Peritoneal Dialysis. He is also the President of the International Association of Chinese Nephrologists (IACN). He is the Co-Chair of International Steering Committee for World Kidney Day. He is the Chairman of the Central Renal Committee of Hospital Authority of Hong Kong. He is the President of the Hong Kong College of Physicians. He has served in the Council and the Executive Committee of the International Society of Nephrology (ISN) from 2005-2011.
Prof. Li has been Visiting Professor and Scholar to Harvard Medical School and Brown University, USA, Nanjing University, Fudan University and Peking University, China and Nagoya University, Japan.
He has published over 540 original and review articles in peer-reviewed journals, 4 books and 20 book chapters. He has given over 200 lectures to international congresses, meetings and academic institutions.
Professor Bernard Canaud is currently Emeritus Professor of Nephrology at the Montpellier University School of Medicine, Montpellier, France. He headed for 25 years the Nephrology, Dialysis and Intensive Care Department at Lapeyronie University Hospital, Montpellier- France.
Main topics of interests are renal replacement therapy, uremic toxicity, vascular access, dialysis efficacy, nutrition, anemia, epidemiology of CKD, practice patterns.
He contributed to the elaboration and production of the European Best Practice Guidelines particularly on dialysis fluid purity, vascular access, dialysis adequacy and anemia management.
He has published 400 peered review manuscripts, contributed in more than 80 textbook chapters and attended more than 1000 scientific medical meetings. H index 62 – i10 index 220
Professor Canaud has acted as Chief Medical Officer for the EMEA-LA region at Fresenius Medical Care Company from 2012 to 2018.
Professor Canaud received several awards and distinctions from international nephrology societies including the prestigious Belding Scribner award from the ISHD in 2010. He received also from the French President in 2009 the “Légion d’Honneur” as recognition for his lifetime of medical achievement. He received in March 2019 the award from the ADC and Missouri University for his lifetime achievement in Nephrology and commitment to renal replacement therapy.
Date and place of birth :
January 4, 1961, Osaka, Japan
Affiliation, title and degree:
Department of Urology, Osaka City University Graduate School of Medicine Associate Professor
Mailing address of affiliated institution :
Department of Urology, Osaka City University Graduate School of Medicine
Tel :06-6645-2392, Fax : 06-6633-9131
Short scientific biography :
1979-1985 M.S. Osaka City University, Faculty of Medicine
1986-1990 D.S. Osaka City University, Department of Urology
1999-2003 Lecturer, Osaka City University, Department of Urology
1993-1998 Instructor, Osaka City University, Department of Urology
2004-present Associate Professor, Osaka City University, Department of Urology
Field of specialization :
Biocompatibility, Hemodialysis, Vascular access
Major professional activities during the past twenty years:
Councilor, Japanese Society for Dialysis Therapy,2002-present
Councilor, International Society for Blood Purification, 1997- present.
Editorial committee,Blood purification, 1997- present
Membership in professional societies :
International Society for Blood Purification,
Japanese Society for Dialysis Therapy
1989 The 7th annual meeting of International Artificial Organs young researcher’s
Peter Kotanko, MD as the Research Director is responsible for the overall direction of the research done at the Renal Research Institute (RRI), New York. RRI’s research spans from basic science to clinical research and from epidemiology to mathematical modeling. After spending a year at RRI in 2005/6, Dr. Kotanko was invited to take over the strategic leadership role of RRI’s research in 2010. He has a background and expertise in physiology, internal medicine, and nephrology, as well as, 20 years of clinical experience. He has authored and co-authored over 300 peer reviewed papers and book chapters. Prior to joining RRI, Dr. Kotanko was the Vice Chair of an Academic Teaching Hospital of the Medical University in Graz, Austria, from 1997 to 2007. From 1982 to 1989, he worked as an Assistant Professor, first in the Department of Physiology, and subsequently at the University Clinic of Internal Medicine, in Innsbruck, Austria. From 1995-1996 Dr. Kotanko trained in nephrology at the Hammersmith Hospital in London, UK. Dr. Kotanko’s current academic appointments are with the Icahn School of Medicine at Mount Sinai, New York, and the Medical University in Innsbruck, Austria.
Emaad Abdel-Rahman, MD, PhD, FASN is a Professor of Internal Medicine/Nephrology at the University of Virginia (UVA). He has been a nephrologist for more than 3 decades.
He is currently the medical director of the in-center hemodialysis unit at UVA, the home hemodialysis program and the kidney clinic. He serves as the vice chief of the Division of Nephrology for Clinical Affairs, the section head of Geriatric Nephrology, and the director of the Nephrology Clinical Research Center.
As a clinician, he overseas patients with all aspects of kidney problems; both in the outpatient and in-patient settings.
He has been involved in multiple clinical research, both investigator initiated and industry-related clinical research, which resulted in more than 70 peer reviewed publications including manuscripts and book chapters as well as being an editor of 4 books.
He has presented in many International/National forum; ASN, RPA, ANNA, ISBP and NKF. He served as a member in the ASN Geraitric Advisory committee as well as Kdney Health Initiative (KHI) steering committee.
Prof Andrew Davenport is a Consultant Nephrologist and Professor of Dialysis & ICU Nephrology at UCL Department of Nephrology,Royal Free Hospital,University College London, with a special interest in acute kidney injury, haemo & peritoneal dialysis and hepato-renal failure.He currently have a range of projects from assessing the relationship between body composition, energy expenditure and dialysis dosing for both peritoneal and haemodialysis patients, to investigation of role of sodium balance and volume status during haemodialysis and changes in blood pressure, and divalent ion balance during haemodialysis and haemodiafiltration. In addition, we have two new series of studies designed to investigate the potential role of newer surrogates for dialysis adequacy plus cardiovascular risk factors in haemodialysis patients.
Dr Nayak is a pioneer in the field of Peritoneal Dialysis (PD) internationally and Cadaver Kidney Transplantation and well known in the areas of Acute Kidney Injury (AKI), Chronic Kidney Disease Management, Critical Care Nephrology including CRRT, Liver Dialysis (MARS & FPSA; Prometheus: Largest series in India). He was responsible for the Country’s first Simultaneous Heart and Kidney Transplantation (SHK). He is also an internationally acknowledged expert in Telemedicine in Dialysis, Reverse ‘Medical’ Innovation & Medical Tourism
As a member of various Task Forces & Committees, he has developed Best Practice Guidelines for CKD and Anaemia management. He is the Chief Co-ordinator of the Asia Pacific Chapter for ISPD and also a Past Councillor of ISPD. Presently the Chair of the Communication & Media of ISPD.
He successfully organized the prestigious 2nd Asian Chapter Meeting of the ISPD, Hyderabad in January 2005 and was also the Co-Director of the 3rd Hemodialysis UniversityTM of ISHD at Hyderabad, March 2014.
He has contributed extensively to International Journals such as KI, AJKD, JASN, NDT, Transplantation Proceedings, PDI, Nephrology, American Journal of Gastroenterology, Contributions to Nephrology, Harvard Business Review, etc. He has authored several invited editorials and book chapters and has delivered invited lectures all over the world such as International Society of Peritoneal Dialysis (ISPD), World Congress of Nephrology, Annual Dialysis Conference USA, International Society of Hemodialysis (ISHD),the prestigious Salzburg Global Seminar to name a few. The Harvard Business Review Magazine cited and applauded his work and mentioned that it had world class outcomes.
Dr. Ikuto Masakane graduated from Yamagata University in 1986.
His interests in nephrology are about chronic dialysis; on-line hemodiafiltraion (HDF), dialysis water quality and QOL of dialysis patients.
He is an executive member of Japanese Society of Dialysis Therapy (JSDT) Renal Data Registry Committee.
He has been working in Yabuki Hospital Group for 18 years and the chairman of the global CKD management division of the group since May 2018.
Almost 600 dialysis patients are treated in YHG.
The most notable topic of recent his activities is “patient-centered dialysis care”. It enables to ameliorate QOL of dialysis patients and finally improve the survival rate.
Dr. Hideki Kawanishi is the vice president and the director of artificial organs & surgery of Tsuchiya General Hospital, JAPAN. He has been an active clinical surgeon for past 40 years and nephrologist for 30 years. He is managing over 1,400 chronic dialysis patients include 200 peritoneal dialysis patients in addition to maintaining acute kidney failure program.
His research for HD has focus on the super high flux dialysis include online HDF modality, and for PD on the pathophysiology and treatment for encapsulating peritoneal sclerosis (EPS), with over 300 successful surgical cases, and clinical usefulness for complementary dialysis (hybrid PD and HD) to maintain log-term PD. He has published over 150 international articles in the field of HD, PD and artificial organs.
He is organized Japanese Society for Dialysis Access (JSDA, President), International Society of Blood Purification (ISBP, President), JSPD, JSHDF (President), and associate editor of Blood Purification, & Journal of Vascular Access and editorial board of Peritoneal Dialysis International. Moreover, he is a position of steering committee for PDOPPS international.
Dr. Andre Kaplan is Professor of Medicine at the University of Connecticut Health Center, Chief of Blood Purification at the John Dempsey Hospital and Medical Director of the UConn Dialysis Center. He was President of the 21st Annual Meeting of the International Society of Blood Purification, President of the 7th World Congress for Apheresis in Buenos Aires in 2009, a member of the Board of Trustees of the American Society of Artificial Internal Organs (ASAIO) and is currently President-Elect of the International Society for Apheresis (ISFA). For the last 35 years, he has been involved with the clinical and laboratory evaluation of various types of blood purification techniques. He has published over 100 articles in both print and internet formats, including numerous topics for the “UpToDate” internet based medical information website. He has been a visiting professor and has delivered over 200 lectures throughout the United States and in over 20 countries on 5 continents.
Dr. Isaac Teitelbaum is Professor of Internal Medicine/Nephrology and Director of the Home Dialysis Program at the University Of Colorado School Of Medicine in Aurora, Colorado. Dr. Teitelbaum has been an active clinical nephrologist for over 35 years. He oversees the care of 55 home dialysis patients- PD and home hemo- in addition to maintaining a busy clinical and consultative practice. Dr. Teitelbaum has been named as one of Denver’s Top Doctors by 5280 Magazine.
Dr. Teitelbaum serves as a consultant to industry and has actively participated in numerous clinical trials and educational workshops. He has published or co-authored over 100 articles and/or book chapters and serves as a reviewer for numerous journals. Dr. Teitelbaum is the immediate past President of the International Society for Peritoneal Dialysis.
2008 – 2014 – member of the Scientific Advisory Board of ERA-EDTA
2011 – 2014 – member of the Council of ERA-EDTA
2015 – chair, Immunonephrology Working Group, ERA-EDTA
2014 – 2017, president, International Society of Blood Purification
Substantial part of the publications deals with diagnosis and treatment of glomerulonephritides, mainly ANCA-positive vasculitis and lupus nephritis, renal and renovascular hypertension, and autosomal dominant polycystic kidney disease (and other genetic diseases of the kidney) and cardiovascular complications of renal failure.
Publications- author or co-author of more than 360 publications according to Pubmed, including New England Journal of Medicine, Lancet, Journal of the American Medical Association, Annals of Internal Medicine, Nephrology, Dialysis, Transplantation, American Journal of Kidney Diseases, Kidney International, Rheumatology, Blood Purification, Kidney and Blood Pressure Research, Journal of Nephrology, Annals of Rheumatic Diseases, Journal of Hypertension, etc.
Science Citation Index more than 9000, Hirsch index 42, editorial board: Nephrology, Dialysis, Transplantation, subject editor, Clinical Journal of the American Society of Nephrology
Organization of international congresses
1999 – president of the 17th Annual Meeting of the International Society of Blood Purification
2003 – president – 11th International ANCA and Vasculitis Workshop
2005 – president – 6th European Meeting on Peritoneal Dialysis
2007 – president of the 25th Annual Meeting of the International Society of Blood Purification
2011 – president of the 48th congress of the European Renal Association/European Dialysis and Transplantation Association
smaller meetings and educational courses: 3rd meeting of the International Federation of Kidney Foundations, meeting of the European Vasculitis Study Group, Nephrology Winter School
Local coordinator and member of the steering committee of several non-commercial studies in vasculitis, organized by European Vasculitis Study Group, some of them supported by the grant of the European (Community) Union – e.g. CYCAZAREM, MEPEX, CYCLOPS, IMPROVE, RITUXVAS, MYCYC, PEXIVAS. Co-author of several papers of this group
Member of the steering committee of large randomized international studies with statins in renal patients (AURORA, SHARP), different studies dedicated to cardiovascular risk factors and cardiovascular complications in CKD patients, SLE, autosomal dominant polycystic kidney disease, diabetic nephropathy, etc.
Founder and organizer of the Czech Registry of Renal Biopsies and the Czech National Registry of ANCA-associated vasculitis
Co-organizer of the large screening study of Fabry disease among the dialysis population in the Czech Republic
Organizer of several Czech cooperative studies in lupus nephritis and hypertension
Prof. Kamyar Kalantar-Zadeh, (a.k.a. Kam Kalantar) is a triple board-certified physician, who studied medicine at the Universities of Bonn and Nuremberg in Germany (MD degree) and received MPH and PhD degrees in Epidemiology from University of California Berkeley, School of Public Health. Dr. Kalantar’s postgraduate training includes an internship training in Nuremberg, Germany, residency training in Internal Medicine and also in Pediatrics in the State University of New York (SUNY, 1993-97), and a nephrology fellowship at University of California San Francisco (UCSF, 1997-2000). During 2000-2012 Dr. Kalantar was a full-time faculty at Harbor-UCLA including Professor of Medicine, Pediatrics and Epidemiology at UCLA. Since 2012 he has served as a tenured Professor and HEAD of the Division of Nephrology and Hypertension at University of California Irvine (UC Irvine) School of Medicine, in Orange and Irvine, CA, and a Professor of Medicine, Pediatrics, and Public Health at UC Irvine and attending nephrologist at UC Irvine as well as Long Beach Veterans Affairs (VA) Hospital. Dr. Kalantar-Zadeh has been recognized by several prestigious top/best physician directories in the USA including SUPER DOCTORS™ and TOP PHYSICIANS™ Castle-Connelly. In 2014 he was ranked among top 10 experts in ESRD and Chronic Kidney Failure by Expertscape™. He serves as the immediate past President of the International Society of Renal Nutrition & Metabolism. President elect of the International Federation of Kidney Foundations and the International Steering Committee of the World Kidney Day. Prof. Kalantar-Zadeh has published over 600 scientific articles, authored many chapters, and presented numerous grand rounds and other lectures in national and international conferences. He is an editor of nephrology and nutrition textbooks including the “Nutritional Management of Renal Disease”, 3rd edition 2013. Dr. Kalantar is an Associate Editor or member of the editorial board of several top journals.
Joanne Bargman is a staff nephrologist at the University Health Network and Professor of Medicine at the University of Toronto. She received her MD cum laude from the University of Toronto and pursued nephrology training at Stanford University. She has more than 800 invited lectures internationally, on subjects as diverse as peritoneal dialysis, glomerulonephritis, and lupus. She is the Director of Peritoneal Dialysis program and co-director of the Combined Renal-Rheumatology Lupus Clinic for the University Health Network.
She won the “Silver Shovel”, given by the graduating medical class of the University of Toronto to the best lecturer in the undergraduate years. She has also won the University of Toronto Faculty of Medicine Postgraduate Teaching Award, given to the best teacher in the postgraduate program. In 2013 she was the recipient of the Donald Seldin Award for excellence in nephrology at the National Kidney Foundation (US). She was the 2015 Recipient of the Lifetime Achievement Award at the Annual Dialysis Conference and the International Distinguished Medal at the Spring Clinical Meetings of the National Kidney Foundation in 2016. In 2018 she was the recipient of the Gabor Zellerman Award for Research and Excellence in Peritoneal Dialysis. She is an Associate Editor of the Journal of the American Society of Nephrology. Dr. Bargman is co-author of the chapter “Chronic Kidney Disease” in the 17th-20th editions of Harrison’s Principles of Internal Medicine.
Rasheed Abiodun Balogun, MBBS FACP FASN HP(ASCP) FMCP is a tenured Professor of Medicine and Medical Director of the Extracorporeal Therapies (Apheresis) Program at University of Virginia. He received his medical training at University of Ibadan, Nigeria and University of Connecticut, USA.
Dr Balogun is a nephrologist with advanced expertise in extra corporeal therapies, the use of highly specialized techniques for blood purification. His clinical and research interests include providing care for patients focusing on prevention and treatment of acute and chronic kidney disease and using extracorporeal therapies like therapeutic apheresis to treat renal, neurological and hematological disorders.
He is a fellow of the American College of Physicians, American Society of Nephrology, National Kidney Foundation and the National Postgraduate Medical College of Nigeria. He created and directs the Therapeutic Apheresis Academy, an annual multidisciplinary national conference. He serves on the executive committee of the UVa faculty senate and was the foundation student affairs dean of the Walter Reed College at UVa. Beyond UVa, he serves on the board of directors of the American Society for Apheresis and a member of the committee that writes “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice”. He is the Chair of the Internal Medicine Steering Committee of the National Medical Association (USA) and also co-chairs it’s Nephrology subsection. He serves as secretary of the International Society of Blood Purification an is currently on the editorial board of the Journal of Clinical Apheresis and previousl the ASAI Journal.
Dr Balogun spends most of his professional time treating patients with kidney disease and teaching others from the level of medical students to continuing medical education of qualfied specialists at an international level.